Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Type of Medium
Language
Region
Library
Years
Keywords
  • 1
    UID:
    almafu_9959327226702883
    Format: 1 online resource (xxviii, 599 pages)
    ISBN: 9781119001348 , 111900134X , 9781119001331 , 1119001331 , 9781119001355 , 1119001358
    Series Statement: Advances in pharmaceutical technology
    Content: "A comprehensive look at existing technologies and processes for continuous manufacturing of pharmaceuticals As rising costs outpace new drug development, the pharmaceutical industry has come under intense pressure to improve the efficiency of its manufacturing processes. Continuous process manufacturing provides a proven solution. Among its many benefits are: minimized waste, energy consumption, and raw material use; the accelerated introduction of new drugs; the use of smaller production facilities with lower building and capital costs; the ability to monitor drug quality on a continuous basis; and enhanced process reliability and flexibility. Continuous Manufacturing of Pharmaceuticals prepares professionals to take advantage of that exciting new approach to improving drug manufacturing efficiency. This book covers key aspects of the continuous manufacturing of pharmaceuticals. The first part provides an overview of key chemical engineering principles and the current regulatory environment. The second covers existing technologies for manufacturing both small-molecule-based products and protein/peptide products. The following section is devoted to process analytical tools for continuously operating manufacturing environments. The final two sections treat the integration of several individual parts of processing into fully operating continuous process systems and summarize state-of-art approaches for innovative new manufacturing principles. Brings together the essential know-how for anyone working in drug manufacturing, as well as chemical, food, and pharmaceutical scientists working on continuous processing Covers chemical engineering principles, regulatory aspects, primary and secondary manufacturing, process analytical technology and quality-by-design Contains contributions from researchers in leading pharmaceutical companies, the FDA, and academic institutions Offers an extremely well-informed look at the most promising future approaches to continuous manufacturing of innovative pharmaceutical products Timely, comprehensive, and authoritative, Continuous Manufacturing of Pharmaceuticals is an important professional resource for researchers in industry and academe working in the fields of pharmaceuticals development and manufacturing"--
    Content: "This book covers key aspects of the continuous manufacturing of pharmaceuticals. The first part provides an overview of key chemical engineering principles and the current regulatory environment. The second covers existing technologies for manufacturing both small-molecule-based products and protein/peptide products. The following section is devoted to process analytical tools for continuously operating manufacturing environments. The final two sections treat the integration of several individual parts of processing into fully operating continuous process systems and summarize state-of-art approaches for innovative new manufacturing principles"--
    Note: Cover; Title Page; Copyright; Contents; About the Editors; List of Contributors; Series Preface; Preface; Chapter 1 Continuous Manufacturing: Definitions and Engineering Principles; 1.1 Introduction; 1.1.1 Definition of Continuous Manufacturing; 1.1.2 Continuous Manufacturing in the Pharmaceutical Industry; 1.1.3 Our View of Continuous Manufacturing; 1.1.4 Regulatory Environment; 1.2 Advantages of Continuous Manufacturing; 1.2.1 Flexibility; 1.2.2 Effect on the Supply Chain; 1.2.3 Agility and Reduced Scale-up Efforts; 1.2.4 Real-Time Quality Assurance and Better Engineered Systems. , 1.2.5 Decentralized Manufacturing1.2.6 Individualized Manufacturing; 1.2.7 Reduced Floor Space and Investment Costs; 1.2.8 More Efficient Chemistries; 1.2.9 Societal Benefits; 1.3 Engineering Principles of Continuous Manufacturing; 1.3.1 Pharmaceutical Unit Operations; 1.3.2 Fundamentals of Process Modeling; 1.3.3 Balance Equations for Mass, Species, Energy and Momentum; 1.3.4 Residence Time Distribution; 1.3.5 Classical Reactor Types as a Basis for Process Understanding; 1.3.6 Process Control, Modeling and PAT; 1.3.7 Scale-Up; 1.3.8 Dimensioning; 1.4 Conclusion; References. , Chapter 2 Process Simulation and Control for Continuous Pharmaceutical Manufacturing of Solid Drug Products2.1 Introduction; 2.1.1 Scope and Motivation; 2.1.2 Process Simulation; 2.1.3 Process Control; 2.2 Pharmaceutical Solid Dosage Manufacturing Processes; 2.2.1 Overview; 2.2.2 Continuous Manufacturing Processes; 2.2.3 Continuous Process Equipment; 2.3 Mathematical Modeling Approaches; 2.3.1 First Principle ""Mechanistic"" Models; 2.3.2 Multi-dimensional Population Balance Models; 2.3.3 Engineering or Phenomenological Models; 2.3.4 Empirical and Reduced Order Models. , 2.4 Unit Operations Models2.4.1 Feeders; 2.4.2 Blenders (Mixers); 2.4.3 Tablet Press; 2.4.4 Roller Compactor; 2.4.5 Wet Granulation; 2.4.6 Drying; 2.4.7 Milling/Co-milling; 2.4.8 Flowsheet Modeling; 2.5 Process Control of Continuous Solid-based Drug Manufacturing; 2.5.1 Process Control Basics; 2.5.2 Control Design of Continuous Pharmaceutical Manufacturing Process; 2.6 Summary; Acknowledgments; References; Chapter 3 Regulatory and Quality Considerations for Continuous Manufacturing; 3.1 Introduction; 3.2 Current Regulatory Environment. , 3.3 Existing Relevant Regulations, Guidelines, and Standards Supporting Continuous Manufacturing3.3.1 ICH Guidelines; 3.3.2 United States Food and Drug Administration Guidances; 3.3.3 US FDA Guidance on Process Validation; 3.3.4 American Society for Testing and Materials Standards; 3.3.5 European Union Guidelines; 3.4 Regulatory Considerations; 3.4.1 Development Considerations for Continuous Manufacturing; 3.4.2 Special Considerations for Control Strategy in Continuous Manufacturing; 3.4.3 Stability Considerations for Continuous Manufacturing; 3.5 Quality/GMP Considerations.
    Additional Edition: Print version: Continuous manufacturing of pharmaceuticals. Hoboken, NJ : John Wiley & Sons Ltd, 2017 ISBN 9781119001324
    Language: English
    Keywords: Electronic books. ; Electronic books. ; Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    almahu_9948198540902882
    Format: 1 online resource (xxviii, 599 pages)
    ISBN: 9781119001348 , 111900134X , 9781119001331 , 1119001331 , 9781119001355 , 1119001358
    Series Statement: Advances in pharmaceutical technology
    Content: "A comprehensive look at existing technologies and processes for continuous manufacturing of pharmaceuticals As rising costs outpace new drug development, the pharmaceutical industry has come under intense pressure to improve the efficiency of its manufacturing processes. Continuous process manufacturing provides a proven solution. Among its many benefits are: minimized waste, energy consumption, and raw material use; the accelerated introduction of new drugs; the use of smaller production facilities with lower building and capital costs; the ability to monitor drug quality on a continuous basis; and enhanced process reliability and flexibility. Continuous Manufacturing of Pharmaceuticals prepares professionals to take advantage of that exciting new approach to improving drug manufacturing efficiency. This book covers key aspects of the continuous manufacturing of pharmaceuticals. The first part provides an overview of key chemical engineering principles and the current regulatory environment. The second covers existing technologies for manufacturing both small-molecule-based products and protein/peptide products. The following section is devoted to process analytical tools for continuously operating manufacturing environments. The final two sections treat the integration of several individual parts of processing into fully operating continuous process systems and summarize state-of-art approaches for innovative new manufacturing principles. Brings together the essential know-how for anyone working in drug manufacturing, as well as chemical, food, and pharmaceutical scientists working on continuous processing Covers chemical engineering principles, regulatory aspects, primary and secondary manufacturing, process analytical technology and quality-by-design Contains contributions from researchers in leading pharmaceutical companies, the FDA, and academic institutions Offers an extremely well-informed look at the most promising future approaches to continuous manufacturing of innovative pharmaceutical products Timely, comprehensive, and authoritative, Continuous Manufacturing of Pharmaceuticals is an important professional resource for researchers in industry and academe working in the fields of pharmaceuticals development and manufacturing"--
    Content: "This book covers key aspects of the continuous manufacturing of pharmaceuticals. The first part provides an overview of key chemical engineering principles and the current regulatory environment. The second covers existing technologies for manufacturing both small-molecule-based products and protein/peptide products. The following section is devoted to process analytical tools for continuously operating manufacturing environments. The final two sections treat the integration of several individual parts of processing into fully operating continuous process systems and summarize state-of-art approaches for innovative new manufacturing principles"--
    Note: Cover; Title Page; Copyright; Contents; About the Editors; List of Contributors; Series Preface; Preface; Chapter 1 Continuous Manufacturing: Definitions and Engineering Principles; 1.1 Introduction; 1.1.1 Definition of Continuous Manufacturing; 1.1.2 Continuous Manufacturing in the Pharmaceutical Industry; 1.1.3 Our View of Continuous Manufacturing; 1.1.4 Regulatory Environment; 1.2 Advantages of Continuous Manufacturing; 1.2.1 Flexibility; 1.2.2 Effect on the Supply Chain; 1.2.3 Agility and Reduced Scale-up Efforts; 1.2.4 Real-Time Quality Assurance and Better Engineered Systems. , 1.2.5 Decentralized Manufacturing1.2.6 Individualized Manufacturing; 1.2.7 Reduced Floor Space and Investment Costs; 1.2.8 More Efficient Chemistries; 1.2.9 Societal Benefits; 1.3 Engineering Principles of Continuous Manufacturing; 1.3.1 Pharmaceutical Unit Operations; 1.3.2 Fundamentals of Process Modeling; 1.3.3 Balance Equations for Mass, Species, Energy and Momentum; 1.3.4 Residence Time Distribution; 1.3.5 Classical Reactor Types as a Basis for Process Understanding; 1.3.6 Process Control, Modeling and PAT; 1.3.7 Scale-Up; 1.3.8 Dimensioning; 1.4 Conclusion; References. , Chapter 2 Process Simulation and Control for Continuous Pharmaceutical Manufacturing of Solid Drug Products2.1 Introduction; 2.1.1 Scope and Motivation; 2.1.2 Process Simulation; 2.1.3 Process Control; 2.2 Pharmaceutical Solid Dosage Manufacturing Processes; 2.2.1 Overview; 2.2.2 Continuous Manufacturing Processes; 2.2.3 Continuous Process Equipment; 2.3 Mathematical Modeling Approaches; 2.3.1 First Principle ""Mechanistic"" Models; 2.3.2 Multi-dimensional Population Balance Models; 2.3.3 Engineering or Phenomenological Models; 2.3.4 Empirical and Reduced Order Models. , 2.4 Unit Operations Models2.4.1 Feeders; 2.4.2 Blenders (Mixers); 2.4.3 Tablet Press; 2.4.4 Roller Compactor; 2.4.5 Wet Granulation; 2.4.6 Drying; 2.4.7 Milling/Co-milling; 2.4.8 Flowsheet Modeling; 2.5 Process Control of Continuous Solid-based Drug Manufacturing; 2.5.1 Process Control Basics; 2.5.2 Control Design of Continuous Pharmaceutical Manufacturing Process; 2.6 Summary; Acknowledgments; References; Chapter 3 Regulatory and Quality Considerations for Continuous Manufacturing; 3.1 Introduction; 3.2 Current Regulatory Environment. , 3.3 Existing Relevant Regulations, Guidelines, and Standards Supporting Continuous Manufacturing3.3.1 ICH Guidelines; 3.3.2 United States Food and Drug Administration Guidances; 3.3.3 US FDA Guidance on Process Validation; 3.3.4 American Society for Testing and Materials Standards; 3.3.5 European Union Guidelines; 3.4 Regulatory Considerations; 3.4.1 Development Considerations for Continuous Manufacturing; 3.4.2 Special Considerations for Control Strategy in Continuous Manufacturing; 3.4.3 Stability Considerations for Continuous Manufacturing; 3.5 Quality/GMP Considerations.
    Additional Edition: Print version: Continuous manufacturing of pharmaceuticals. Hoboken, NJ : John Wiley & Sons Ltd, 2017 ISBN 9781119001324
    Language: English
    Keywords: Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Did you mean 9781119003335?
Did you mean 9781118701355?
Did you mean 9781119001362?
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages